Protazil® is the first FDA-approved alfalfa-based, pelleted treatment for equine protozoal myeloencephalitis (EPM).
- Active Ingredients: 1.56% diclazuril
- Product Information: One 2.4-lb pail of PROTAZIL® will treat one 1100-lb horse for 28 days. This product is made for Merck Animal Health
- Directions for User: PROTAZIL® (1.56% diclazuril) is administered as a top dress in the horse’s daily grain ration at a rate of 1 mg diclazuril per kg (0.45 mg diclazuril/lb) of body weight for 28 days. The quantity of PROTAZIL® necessary to deliver this dose is 64 mg pellets per kg (29 mg pellets/lb) of body weight.
- Special Precautions: The safe use of PROTAZIL® (1.56% diclazuril) Antiprotozoal Pellets in horses used for breeding purposes, during pregnancy, or in lactating mares has not been evaluated. The safety of PROTAZIL® (1.56% diclazuril) Antiprotozoal Pellets with concomitant therapies in horses has not been evaluated.
- Note: Includes Calibrated scoop